PGAM2 p.Arg86Cys
c.256C>T · rs371509257 · VCV855880
Computational evidence
| Protein change | ||
| AlphaMissense | 0.666 | likely pathogenic |
|---|---|---|
| REVEL | 0.579 | indeterminate |
| SaProt | LLR -13.18 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 2,762 bp · p 0.7 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.101% | 987 |
| Remaining individualsnot grpmax-eligible | 0.0112% | 8,926 |
| Admixed Americangrpmax | 0.005% | 20,001 |
| European (non-Finnish) | 0.0011% | 90,773 |
| South Asian | 0.0011% | 91,094 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PGAM2
- Protein
- p.Arg86Cys
- Coding
- c.256C>T
- MANE Select
- NM_000290
- dbSNP
- rs371509257
- Type
- single nucleotide variant
- Location
- chr7:44065274 (GRCh38)
- Gene constraint
- LOEUF 1.421 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.07
Disease context
glycogen storage disease due to phosphoglycerate mutase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glycogen storage disease due to phosphoglycerate mutase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Childhood
Similar variants
- PGAM2 p.Lys39Gln Uncertain significance ★★ ⚠ same condition
- PGAM2 p.Gln111Ter Pathogenic ★ same condition
- PGAM2 p.Trp78Ter Pathogenic ★ same condition
- PGAM2 p.Ala204Val Uncertain significance ★ same condition
- PGAM2 p.Arg40Gln Conflicting classifications of pathogenicity ★ ⚠ same condition
- PGAM2 p.Arg5Cys Uncertain significance ★ ⚠ same condition
- PGAM2 p.Arg65Cys Uncertain significance ★ same condition
- PGAM2 p.Gly144Asp Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgam2-p-arg86cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown